The association of radical prostatectomy and adjuvant hormone therapy can represent a valid option in the treatment of locally advanced prostatic cancer (T3b-c)?
Restricted accessResearch articleFirst published online June, 1996
The association of radical prostatectomy and adjuvant hormone therapy can represent a valid option in the treatment of locally advanced prostatic cancer (T3b-c)?
Locally advanced prostatic cancer is a pathological condition not uncommonly found, especially during radical prostatectomy due to an understaged pathology. It is therefore important to find a pattern of therapeutic behaviour in order to be able to offer the patient the most suitable treatment. An analysis of current case histories tallies with other recent statistical evaluations and allows us to state with increasing certainty that the combination of radical prostatectomy, when technically feasible, with a supporting hormone therapy offers numerous advantages in terms of life span, free-from-disease intervals and quality of life compared to the single therapies. It is therefore interesting to examine the role that such therapy plays in the treatment of locally advanced prostatic cancer.
EntarV.L.: Prostatic cancer: mortality and incidence rates by race and social class. Am. J. Epidemiol., 107: 311, 1992.
2.
RaveryV., LimotO., TobolskiF., Boccon-GibodL. A., ToublancM., HermieuJ.F., DelmasV., Boccon-GibodL.: Advances in the assessment of clinically localized prostate cancer. Eur. Urol., 29: 257–265, 1996.
3.
AusG., HugssonJ., And NorlenL.: Long-term survival and mortality in prostate cancer treated with noncurative intent. J. Urol., 154: 460–465, 1995.
4.
StameyT., McNealJ.: L'adenocarcinoma della prostata. In: Urologia di Campbell, pp. 1226–1228–1229–1257, Verduci Editore 1993, dall'edizione inglese del 1992.
5.
SchroderF.H., Dies van denOuden, DavidsonP.: The limits of surgery in the cure of prostatic carcinoma. European Urology Update series, vol. 1, n. 3, 1992.
6.
ZinckeH., UtzD.C., TaylorW.F.: Bilateral pelvic lymphadenectomy and radical prostatectomy for clinical stage C prostatic cancer: role of adjuvant treatment for residual cancer and in disease progression. J. Urol., 135: 1199–1205, 1986.
7.
ZinckeH., BergstralhE.J., Larson-KellerJ. J., FarrowG., MyersR.B., LieberM.M., BarretD.M., RifeC.C., GonchoroffM.J.: Stage D1 prostate cancer treated by radical prostatectomy and adjuvant hormonal treatment. Cancer, 70 (suppl. 1): 311–323, 1992.
8.
ChengW.S., BergstralhE.J., FrydenbergM., ZinckeH.: PSA levels after radical prostatectomy and immediate adjuvant hormonal treatment for stage D1 prostate cancer are predictive of early disease outcome. Eur. Urol., 25: 189–193, 1994.
9.
JewettH.J.: Treatment of early cancer of the prostate. Jama, 183 (5): 373–375, 1963.
10.
IsaacsJ.T., CoffeyD.: Adaptation versus selection as the mechanism responsible for the relapse of prostatic cancer to androgen ablation therapy as studied in the Dunning R-3327-H adenocarcinoma. Cancer Research, 41: 5070–5075, 1981.
11.
WalshP.C.: La prostatectomia radicale retropubica. In: Urologia di Campbell, pp. 2997–3018. Verduci Editore 1993, dall'edizione inglese del 1992.
12.
HulandH.: The risks outweigh the benefits of radical prostatectomy in localised cancer: the argument against. Eur. Urol., 29 (suppl. 2): 31–33, 1996.
13.
KerrL.A., ZinckeH.: Radical retropubic prostatectomy for prostate cancer in the elderly and the young: complications and prognosis. Eur. Urol., 25: 305–312, 1994.
14.
de KernionJ.B., NeuwirthH., SteinA., DoreyF., StenziA., HannahJ., BlythB.: Prognosis of patients with stage D1 prostate carcinoma following radical prostatectomy with and without early endocrine therapy. J. Urol., 144; 700–703, 1990.
15.
WenderothU.K., KleinschmidtK., dePetriconiR., HautmannE.: Should radical prostatectomy be the treatment of choice for patients with locally advanced prostatic carcinoma. Abstract 181-XIth Congress of the European Association of Urology, 13/16 settembre 1994.
16.
FrohmullerH.G.W., TheissM., ManseckA., WirthM.P.: Survival and quality of life of patients with stage D1 (T1-3 pN1-2 M0) prostate cancer. Eur. Urol., 27, 202–206, 1995.
17.
GerberG.S., ThistedR.A., ChodakG.W., RukstalisD.B., PaulsonD.F.: Results of radical prostatectomy in men with locally advanced (clinical stage T3) prostate cancer (Cal): multi-institutional analysis. J. Urol., 155 (suppl. 96): 1194, Congr. AUA 4/9 maggio 1996.
